z-logo
open-access-imgOpen Access
Development of RGD-modified nanoparticles with epigallocatechin gallate (EGCG) loading as ophthalmic nanomedicine to inhibit corneal neovascularization development
Author(s) -
Tseng Ching-Li,
Takuya Miyagawa,
Zhiyu Chen,
Wang Yang-Kao,
Liu Guei-Sheung,
Mingchen Wang
Publication year - 2016
Publication title -
frontiers in bioengineering and biotechnology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.081
H-Index - 44
ISSN - 2296-4185
DOI - 10.3389/conf.fbioe.2016.01.01431
Subject(s) - cornea , nanomedicine , medicine , gelatin , corneal neovascularization , neovascularization , ophthalmology , hyaluronic acid , diabetic retinopathy , pharmacology , nanoparticle , chemistry , cancer research , angiogenesis , materials science , nanotechnology , biochemistry , anatomy , endocrinology , diabetes mellitus

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here